OESTROGENS, CONJUGATED and BAZEDOXIFENE ACETATE tablets (Duavive®) - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

OESTROGENS, CONJUGATED and BAZEDOXIFENE ACETATE tablets (Duavive®)

Last Updated: 28 June 2017

Body System: Endocrine System

Black

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of CONJUGATED OESTROGENS and BAZEDOXIFENE 0.45mg/20mg modified release tablets (Duavive®) for the treatment of oestrogen deficiency in postmenopausal women with a uterus.